Brain uptake and utilization of fatty acids, lipids and lipoproteins: Application to neurological disorders

Journal of Molecular Neuroscience

Volumn 33, Issue 1, 2007, Pages 2-11

  Hamilton, James A ^a   Hillard, Cecilia J ^b   Spector, Arthur A ^c   Watkins, Paul A ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Adrenoleukodystrophy; Alzheimer's disease; Blood brain barrier; Brain lipids; Brain uptake; Fatty acid

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSANOID; LIPID; LIPOPROTEIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID;

BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN FUNCTION; BRAIN METABOLISM; CONFERENCE PAPER; FAT INTAKE; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; GLIA CELL; HUMAN; LIPID METABOLISM; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MOLECULAR BIOLOGY; NERVE CELL; NERVE CELL MEMBRANE; NEUROLOGIC DISEASE; NONHUMAN; NUTRITION; TOXICITY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; EDUCATION; EICOSANOIDS; FATTY ACIDS; HUMANS; LIPID METABOLISM; LIPOPROTEINS; NERVOUS SYSTEM DISEASES;

EID: 35348879692     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-007-0060-1     Document Type: Conference Paper

References (63)

1. Abumrad, N. A., el-Maghrabi, M. R., Amri, E. Z., Lopez, E.,& Grimaldi, P. A. (1993). Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. Journal of Biological Chemistry, 268, 17665-17668.
2. Alkayed, N. J., Goyagi, T., Joh, H. D., Klaus, J., Harder, D. R., Traystman, R. J., et al. (2002). Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke, 33, 1677-1684.
3. Andreasson, K. I., Savonenko, A., Vidensky, S., Goellner, J. J., Zhang, Y., Shaffer, A., et al. (2001). Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. Journal of Neuroscience, 21, 8198-8209.
4. Arlt, S., Beisiegel, U., & Kontush, A. (2002). Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease. Current Opinion in Lipidology, 13, 289-294.
5. Bazan, N. G., Colangelo, V., & Lukiw, W. J. (2002). Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins & Other Lipid Mediators, 68-69, 197-210.
6. Beffert, U., Stolt, P. C., & Herz, J. (2004). Functions of lipoprotein receptors in neurons. Journal of Lipid Research, 45, 403-409.
7. Beisiegel, U., & Spector, A. A. (2001). Lipids and lipoproteins in the brain. Current Opinion in Lipidology, 12, 243-244.
8. Coe, N. R., Smith, A. J., Frohnert, B. I., Watkins, P. A., & Bernlohr, D. A. (1999). The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. Journal of Biological Chemistry, 274, 36300-36304.
9. Cunnane, S. C., Williams, S. C., Bell, J. D., Brookes, S., Craig, K., Iles, R. A., et al. (1994). Utilization of uniformly labeled 13C-polyunsaturated fatty acids in the synthesis of long-chain fatty acids and cholesterol accumulating in the neonatal rat brain. Journal of Neurochemistry, 62, 2429-2436.
10. Edmond, J., Higa, T. A., Korsak, R. A., Bergner, E. A., & Lee, W. -N. P. (1998). Fatty acid transport and utilization for the developing brain. Journal of Neurochemistry, 70, 1227-1234.
11. Fam, S. S., & Morrow, J. D. (2003). The isoprostanes: Unique products of arachidonic acid oxidation - a review. Current Medicinal Chemistry, 10, 1723-1740.
12. Fam, S. S., Murphey, L. J., Terry, E. S., Zackert, W. E., Chen, Y., & Gao, L., et al. (2002). Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. Journal of Biological Chemistry, 277, 36076-36084.
13. Febbraio, M., Guy, E., Coburn, C., Knapp, F. F., Jr., Beets, A. L., Abumrad N. A., et al. (2002). The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36. Molecular and Cellular Biochemistry, 239, 193-197.
14. Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., & Makriyannis, A., et al. (2004). Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proceedings of the National Academy of Sciences of the United States of America, 101, 8756-8761.
15. Fischer, H., Gottschlich, R., & Seelig, A. (1998). Blood-brain barrier permeation: Molecular parameters governing passive diffusion. Journal of Membrane Biology, 165, 201-211.
16. Freed, L. M., Wakabayashi, S., Bell, J. M., & Rapoport, S. I. (1994). Effect of inhibition of beta-oxidation on incorporation of [U-14C]palmitate and [1-14C]arachidonate into brain lipids. Brain Research, 645, 41-48.
17. Gerdeman, G. L., Partridge, J. G., Lupica, C. R., & Lovinger, D. M. (2003). It could be habit forming: Drugs of abuse and striatal synaptic plasticity. Trends Neurosci, 26, 184-192.
18. Glaser, S. T., Abumrad, N. A., Fatade, F., Kaczocha, M., Studholme, K. M., & Deutsch, D. G. (2003). Evidence against the presence of an anandamide transporter. Proceedings of the National Academy of Sciences of the United States of America, 100, 4269-4274.
19. Guo, W., Huang, N., Cai, J., Xie, W., & Hamilton, J. A. (2006). Fatty acid transport and metabolism in HepG2 cells. American Journal of Physiology: Gastrointestinal and Liver Physiology, 290, G528-G534.
20. Hamilton, J. A., Guo, W., & Kamp, F. (2002). Mechanism of cellular uptake of long-chain fatty acids: Do we need cellular proteins? Molecular and Cellular Biochemistry, 239, 17-23.
21. Herrmann, T., Buchkremer, F., Gosch, I., Hall, A. M., Bernlohr, D. A., & Stremmel, W. (2001). Mouse fatty acid transport protein 4 (FATP4): Characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene, 270, 31-40.
22. Herz, J. (2003). LRP: A bright beacon at the blood-brain barrier. Journal of Clinical Investigation, 112, 1483-1485.
23. Hillard, C. J. (2000). Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins & Other Lipid Mediators, 61, 3-18.
24. Hillard, C. J., & Jarrahian, A. (2000). The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chemistry and Physics of Lipids, 108, 123-134.
25. Hui, T. Y., & Bernlohr, D. A. (1997). Fatty acid transporters in animal cells. Frontiers in Bioscience, 2, 222-231.
26. Kamp, F., Hamilton, J. A., & Westerhoff, H. V. (1993). Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers. Biochemistry, 32, 11074-11086.
27. Kamp, F., Zakim, D., Zhang, F., Noy, N., & Hamilton, J. A. (1995). Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry, 34, 11928-11937.
28. Kamp, F., Guo, W., Souto, R., Pilch, P. F., Corkey, B. E., & Hamilton, J. A. (2003). Rapid flip-flop of oleic acid across the plasma membrane of adipocytes. Journal of Biological Chemistry, 7988-7995.
29. Kehl, F., Cambj-Sapunar, L., Maier, K. G., Miyata, N., Kametani, S., Okamoto, H., et al. (2002). 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. American Journal of Physiology Heart and Circulatory Physiology, 282, H1556-1565.
30. Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., et al. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proceedings of the National Academy of Sciences of the United States of America, 94, 4318-4323.
31. Mahley, R. W., & Huang, Y. (1999). Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond. Current Opinion in Lipidology, 10, 207-217.
32. Martinez, M. (1992). Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Brain Research, 583, 171-182.
33. Martinez, M., Mougan, I. Roig, M., & Ballabriga, A. (1994). Blood polyunsaturated fatty acids in patients with peroxisomal disorders - A multicenter study. Lipids, 29, 273-280.
34. Martinez, M. (1996). Docosahexaenoic acid therapy in docosahexaenoic acid-deficient patients with disorders of peroxisomal biogenesis. Lipids, 31, S145-S152.
35. Martinez, M., & Vazquez, E. (1998). MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology, 51, 26-32.
36. Montine, T. J., Milatovic, D., Gupta, R. C., Valyi-Nagy, T., Morrow, J. D., & Breyer, R. M. (2002a). Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. Journal of Neurochemistry, 83, 463-470.
37. Montine, T. J., Neely, M. D., Quinn, J. F., Beal, M. F., Markesbery, W. R., Roberts, L. J., et al. (2002b). Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biology & Medicine, 33, 620-626.
38. Morell, P., & Toews, A. D. (1996). Biochemistry of Lipids. In Moser, H. W. (Ed.), Handbook of Clinical Neurology, Vol. 22 (66): Neurodystrophies and Neurolipidoses (pp. 33-49). Amsterdam: Elsevier.
39. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., et al. (2003). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Archives of Neurology, 60, 940-946.
40. Moser, H. W. (1997). Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain, 120, 1485-1508.
41. Moser, H. W., Raymond, G. V., Koehler, W., Sokolowski, P., Hanefeld, F., & Korenke, G. C., et al. (2003). Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: Results of two concurrent trials. Advances in Experimental Medicine and Biology, 544, 369-387.
42. Mostofsky, D. I., Yehuda, S., & Salem, N., Jr. (2001). Fatty acids: Physiological and behavioral functions. Totowa, NJ: Humana Press, Nutrition and Health.
43. Noronha, J. G., Bell, J. M., & Rapoport, S. I. (1990). Quantitative brain autoradiography of [9,10-3H]palmitic acid incorporation into brain lipids. Journal of Neuroscience Research, 26, 196-208.
44. Pawlosky, R. J., Ward, G., & Salem, N., Jr. (1996). Essential fatty acid uptake and metabolism in the developing rodent brain. Lipids, 31 (Suppl), S103-S107.
45. Petroni, A., Bertagnolio, B., La Spada, P., Blasevich, M., Papini, N., & Govoni, S., et al. (1998). The beta-oxidation of arachidonic acid and the synthesis of docosahexaenoic acid are selectively and consistently altered in skin fibroblasts from three Zellweger patients versus X-adrenoleukodystrophy, Alzheimer and control subjects. Neuroscience Letters, 250, 145-148.
46. Purdon, D., Arai, T., & Rapoport, S. (1997). No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. Journal of Lipid Research, 38, 526-530.
47. Rapoport, S. I. (2001). In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. Journal of Molecular Neuroscience, 16, 243-261; discussion 279-284.
48. Rapoport, S. I., Chang, M. C., & Spector, A. A. (2001). Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. Journal of Lipid Research, 42, 678-685.
49. Schaffer, J. E., & Lodish, H. F. (1994). Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell, 79, 427-436.
50. Soderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991). Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids, 26, 421-425.
51. Sprecher, H., Luthria, D. L., Mohammed, B. S., & Baykousheva, S. P. (1995). Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. Journal of Lipid Research, 36, 2471-2477.
52. Sprecher, H., Chen, Q., & Yin, F. Q. (1999). Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: A complex intracellular process. Lipids, 34, S153-156.
53. Stahl, A. (2004). A current review of fatty acid transport proteins (SLC27). PfluÉgers Archiv, 447, 722-727.
54. Steinberg, S. J., Wang, S. J., Kim, D. G., Mihalik, S. J., & Watkins, P. A. (1999a). Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism. Biochemical and Biophysical Research Communications, 257, 615-621.
55. Steinberg, S. J., Wang, S. J., McGuinness, M. C., & Watkins, P. A. (1999b). Human liver-specific very-long-chain acyl-coenzyme A synthetase: cDNA cloning and characterization of a second enzymatically active protein. Molecular Genetics and Metabolism, 68, 32-42.
56. Stremmel, W., Strohmeyer, G., Borchard, F., Shaul, K., & Berk, P.D. (1985). Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membrane. Proceedings of the National Academy of Sciences of the United States of America, 82, 4-8.
57. Terracina, L., Brunetti, M., Avellini, L., De Medio, G.E., Trovarelli, G., & Gaiti, A. (1992). Arachidonic and palmitic acid utilization in aged rat brain areas. Molecular and Cellular Biochemistry, 115, 35-42.
58. Theda, C., Moser, A. B., Powers, J. M., & Moser, H. W. (1992). Phospholipids in X-linked adrenoleukodystrophy white matter - Fatty acid abnormalities before the onset of demyelination. Journal of the Neurological Sciences, 110, 195-204.
59. Urano, S., Sato, Y., Otonari, T., Makabe, S., Suzuki, S., Ogata, M., et al. (1998). Aging and oxidative stress in neurodegeneration. Biofactors, 7, 103-112.
60. Vidensky, S., Zhang, Y., Hand, T., Goellner, J., Shaffer, A., Isakson, P., et al. (2003). Neuronal overexpression of COX-2 results in dominant production of PGE2 and altered fever response. Neuromolecular Med, 3, 15-28.
61. Watkins, P. A., Hamilton, J. A., Leaf, A., Spector, A. A., Moore, S. A., Anderson, R. E., et al. (2001). Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases. Journal of Molecular Neuroscience, 16, 87-92 (discussion 151-157).
62. Yepes, M., Sandkvist, M., Moore, E. G., Bugge, T. H., Strickland, D. K., & Lawrence, D. A. (2003). Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. Journal of Clinical Investigation, 112, 1533-15340.
63. Zhang, C., & Harder, D. R. (2002). Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocytic epoxyeicosatrienoic Acid. Stroke, 33, 2957-2964.